Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement regarding the change in the proportion of convertible bond holdings by bondholders reaching 10%.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.